TY - JOUR AU - Chi, Ying AU - Liu, Rong AU - Zhou, Zhi-xuan AU - Shi, Xiao-dong AU - Ding, Yu-chuan AU - Li, Jian-guo PY - 2021 DA - 2021/04/01 TI - Ruxolitinib treatment permits lower cumulative glucocorticoid dosing in children with secondary hemophagocytic lymphohistiocytosis JO - Pediatric Rheumatology SP - 49 VL - 19 IS - 1 AB - This study aimed to analyze the effects of ruxolitinib on children with secondary hemophagocytic lymphohistiocytosis (HLH). SN - 1546-0096 UR - https://doi.org/10.1186/s12969-021-00534-0 DO - 10.1186/s12969-021-00534-0 ID - Chi2021 ER -